A hardcoded ClickUp API key exposed hundreds of corporate and government emails for over a year, raising new SaaS security ...
Novo Nordisk has reported the first mid-stage clinical data with its triple G agonist for diabetes in China, as it starts an international trials programme. The drug candidate, UBT251, acts on GLP-1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results